Organization
APR Applied Pharma Research
5 clinical trials
Clinical trial
ZYESAMI (Aviptadil) for the Treatment of Critical COVID-19 With Respiratory FailureStatus: Completed, Estimated PCD: 2021-02-22
Clinical trial
Inhaled ZYESAMI (Aviptadil Acetate) for the Treatment of Severe COVID-19 (AVICOVID-3)Status: Withdrawn, Estimated PCD: 2022-06-15
Clinical trial
Inhaled ZYESAMI™ for the Treatment of Severe COVID-19Status: Terminated, Estimated PCD: 2021-12-15
Clinical trial
A Pilot, Phase 1, Randomized, Open-Label, Single-Dose, Four-Way Crossover Study to Compare the Pharmacokinetics of Sapropterin Dihydrochloride 100 mg/mL Oral Suspension (Product Code: RLF-OD032) (Test) With Kuvan® (Sapropterin Dihydrochloride) 100 mg Powder for Oral Solution (Reference) and to Evaluate the Effect of Food and the Effect of Water on the Bioavailability of Sapropterin Dihydrochloride 100 mg/mL Oral Suspension in Healthy SubjectsStatus: Not yet recruiting, Estimated PCD: 2024-08-31